Register Now: Beyond EDC: Designing a Connected Data Strategy for Predictive Clinical Development
|Articles|January 14, 2014

ACRP Announces TransCelerate's Intentions to Accept its Certification

Clinical research professionals who have a current CPI or CCRC designation will be able to use that as evidence that retaking GCP training is not necessary if they are working on a trial for one of the TransCelerate companies.

The ACRP announced that TransCelerate BioPharma is accepting its affiliate’s certifications for Certified Clinical Research Coordinator (CCRC®) and Certified Physician Investigator (CPI®) as evidence of Good Clinical Practice (GCP) training.

That TransCelerate’s membership companies are accepting these certifications to eliminate redundant GCP training for each and every new study team the coordinators or investigators join is not a surprise. This initiative to create efficiencies in the clinical trials process was one of the original five targets set forth in TransCelerate’s formation. Specifically, at that time it said of Site Qualification and Training , its goal was “To build upon the creation of common criteria for mutual recognition of GCP training and common forms to collect generic information about study sites, TransCelerate will provide a common framework to streamline the process for qualifying investigator sites, and standardizing non-protocol specific forms for clinical trials. The organization will also establish criteria for training site personnel new to clinical research and trials.”

The ACRP affiliate--the Academy of Clinical Research Professionals (the Academy)--have produced more than 28,500 certificants in more than 60 countries since 1992 (including the CPI, CCRC, and Certified Clinical Research Associate [CCRA®] programs.

At posting time, TransCelerate had not yet posted its release or comments. You can read the ACRP's full release here.


Related to this article

© photon_photo - © photon_photo - stock.adobe.com
Standardized measurement across five oncology centers found that clinical research coordinators rated eSource-enabled workflows positively (Overall Mean Satisfaction 5.79 of 7), with reduced manual entry and electronic data transfer earning strong marks, while perceived reduction in sponsor and monitor queries lagged as the one domain below threshold.
Where the Industry Is Headed as Clinical, Operational, and Real-World Data Connect
In this video interview, Rajneesh Patil, global head of AI, digital, and innovation in clinical development at Syneos Health, describes the industry’s trajectory toward a unified intelligence orchestration environment—and explains why the future isn’t one model that knows everything, but a trusted system that brings the right evidence to the right human decision.